1. Brar, SS, Leon, MB, Stone, GW, et al. Use of drug-eluting stents in acute myocardial infarction: a systematic review and meta-analysis. J Am Coll Cardiol 2009; 53: 1677–1689.
Google Scholar | Crossref | Medline2. Kirtane, AJ, Gupta, A, Iyengar, S, et al. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies. Circulation 2009; 119: 3198–3206.
Google Scholar | Crossref | Medline | ISI3. Stolker, JM, Cohen, DJ, Kennedy, KF, et al. Repeat revascularization after contemporary percutaneous coronary intervention: an evaluation of staged, target lesion, and other unplanned revascularization procedures during the first year. Circ Cardiovasc Interv 2012; 5: 772–782.
Google Scholar | Crossref | Medline4. Adlam, D, Evans, N, Malhotra, A, et al. Repeat percutaneous coronary revascularization: indications and outcomes in a “real world” cohort. Catheter Cardiovasc Interv 2012; 80: 539–545.
Google Scholar | Crossref | Medline5. Chacko, R, Mulhearn, M, Novack, V, et al. Impact of target lesion and nontarget lesion cardiac events on 5-year clinical outcomes after sirolimus-eluting or bare-metal stenting. JACC Cardiovasc Interv 2009; 2: 498–503.
Google Scholar | Crossref | Medline6. Leon, MB, Allocco, DJ, Dawkins, KD, Baim, DS. Late clinical events after drug-eluting stents: the interplay between stent-related and natural history-driven events. JACC Cardiovasc Interv 2009; 2: 504–512.
Google Scholar | Crossref | Medline7. Fineschi, M, Zaca, V, Gori, T, Casini, S, Sinicropi, G, Pierli, C. Long-term outcome after drug-eluting stents implantation: target lesion versus nontarget lesion repeated intervention. Int J Cardiol 2010; 145: 322–324.
Google Scholar | Crossref | Medline8. Shiomi, H, Morimoto, T, Kitaguchi, S, et al. The ReACT trial: randomized evaluation of routine follow-up coronary angiography after percutaneous coronary intervention trial. JACC Cardiovasc Interv 2017; 10: 109–117.
Google Scholar | Crossref | Medline9. Misumida, N, Kobayashi, A, Kim, SM, Abdel-Latif, A, Ziada, KM. Role of routine follow-up coronary angiography after percutaneous coronary intervention - systematic review and meta-analysis. Circ J 2017; 82: 203–210.
Google Scholar | Crossref | Medline10. Moons, KG, Altman, DG, Reitsma, JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015; 162: W1–W73.
Google Scholar | Crossref | Medline | ISI11. Ju, Z, Gao, RL. 2016 Chinese guidelines for the management of dyslipidemias in adults. Chinese Cir J 2016; 31: 937–953.
Google Scholar12. Pencina, ME, D’Agostino, RS, D’Agostino, RJ, Vasan, RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008; 27: 157–172, discussion 207-12.
Google Scholar | Crossref | Medline | ISI13. Vickers, AJ, Elkin, EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006; 26: 565–574.
Google Scholar | SAGE Journals | ISI14. Sanidas, EA, Mintz, GS, Maehara, A, et al. Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression. JACC Cardiovasc Imaging 2012; 5(3 suppl l): S95–S105.
Google Scholar | Crossref | Medline15. Park, MW, Seung, KB, Kim, PJ, et al. Long-term percutaneous coronary intervention rates and associated independent predictors for progression of nonintervened nonculprit coronary lesions. Am J Cardiol 2009; 104: 648–652.
Google Scholar | Crossref | Medline | ISI16. Lemesle, G, de Labriolle, A, Bonello, L, et al. Incidence, predictors, and outcome of new, subsequent lesions treated with percutaneous coronary intervention in patients presenting with myocardial infarction. Am J Cardiol 2009; 103: 1189–1195.
Google Scholar | Crossref | Medline17. Alexopoulos, D, Xanthopoulou, I, Davlouros, P, et al. Mechanisms of nonfatal acute myocardial infarction late after stent implantation: the relative impact of disease progression, stent restenosis, and stent thrombosis. Am Heart J 2010; 159: 439–445.
Google Scholar | Crossref | Medline18. Zheng, C, Kang, J, Park, KW, et al. The predictors of target lesion revascularization and rate of in-stent restenosis in the second-generation drug-eluting stent era. J Interv Cardiol 2019; 2019: 3270132.
Google Scholar | Crossref | Medline19. Hess, CN, Rao, SV, Dai, D, et al. Predicting target vessel revascularization in older patients undergoing percutaneous coronary intervention in the drug-eluting stent era. Am Heart J 2014; 167: 576–584.e2.
Google Scholar | Crossref | Medline20. Han, T, Wang, Q, Yang, H, et al. Risk factors for repeat percutaneous coronary intervention in young patients (≤ 45 years of age) with acute coronary syndrome. Peer J 2019; 7: e6804.
Google Scholar | Crossref | Medline21. Onuma, Y, Kukreja, N, Daemen, J, et al. Impact of sex on 3-year outcome after percutaneous coronary intervention using bare-metal and drug-eluting stents in previously untreated coronary artery disease: insights from the RESEARCH (Rapamycin-eluting stent evaluated at rotterdam cardiology hospital) and T-SEARCH (taxus-stent evaluated at rotterdam cardiology hospital) registries. JACC Cardiovasc Interv 2009; 2: 603–610.
Google Scholar | Medline22. Stefanini, GG, Kalesan, B, Pilgrim, T, et al. Impact of sex on clinical and angiographic outcomes among patients undergoing revascularization with drug-eluting stents. JACC Cardiovasc Interv 2012; 5: 301–310.
Google Scholar | Crossref | Medline23. Bayturan, O, Kapadia, S, Nicholls, SJ, et al. Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol. J Am Coll Cardiol 2010; 55: 2736–2742.
Google Scholar | Crossref | Medline | ISI24. Kamstrup, PR, Tybjaerg-Hansen, A, Nordestgaard, BG. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J Am Coll Cardiol 2013; 61: 1146–1156.
Google Scholar | Crossref | Medline | ISI25. Izzo, P, Macchi, A, De Gennaro, L, Gaglione, A, Di Biase, M, Brunetti, ND. Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options. Eur Heart J Acute Cardiovasc Care 2012; 1: 158–169.
Google Scholar | SAGE Journals26. Garg, S, Serruys, PW, Silber, S, et al. The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE all comers trial. JACC Cardiovasc Interv 2011; 4: 432–441.
Google Scholar | Crossref | Medline27. Stone, GW, Maehara, A, Lansky, AJ, et al. A prospective natural-history study of coronary atherosclerosis. N Engl J Med 2011; 364: 226–235.
Google Scholar | Crossref | Medline | ISI28. Wu, Y, Fu, X. Comprehensive analysis of predictive factors for rapid angiographic stenotic progression and restenosis risk in coronary artery disease patients underwent percutaneous coronary intervention with drug-eluting stents implantation. J Clin Lab Anal 2019; 33: e22666.
Google Scholar | Crossref | Medline29. Lee, CH, Kang, DY, Han, M, et al. Differential cutoff points and clinical impact of stent parameters of various drug-eluting stents for predicting major adverse clinical events: an individual patient data pooled analysis of seven stent-specific registries and 17,068 patients. Int J Cardiol 2019; 282: 17–23.
Google Scholar | Crossref | Medline